Event JSON
{
"id": "805f97e85c20be1bea95029920bce25cf3211718ebe7e4c054e350d76b86e43c",
"pubkey": "daee172c03e1fe2acd7d5d3e148bfe6af1737a38ceb731850f5ba8cca748f527",
"created_at": 1745542623,
"kind": 1,
"tags": [
[
"t",
"bristol"
],
[
"t",
"britain"
],
[
"t",
"england"
],
[
"t",
"greatbritain"
],
[
"t",
"uk"
],
[
"t",
"unitedkingdom"
],
[
"imeta",
"url https://media.pubeurope.com/media_attachments/files/114/395/881/365/226/386/original/7fcd1b5b2a0b7877.webp",
"m image/webp",
"dim 652x435",
"blurhash UFR{x*s:~qf+-;ayM{j[?ua{IUaxMyjZxuj]"
],
[
"proxy",
"https://pubeurope.com/users/uk/statuses/114395881384516097",
"activitypub"
],
[
"client",
"Mostr",
"31990:6be38f8c63df7dbf84db7ec4a6e6fbbd8d19dca3b980efad18585c46f04b26f9:mostr",
"wss://relay.mostr.pub"
]
],
"content": "https://www.europesays.com/uk/48032/ Bristol Myers says schizophrenia drug launch ‘off to a solid start’ #Bristol #Britain #England #GreatBritain #UK #UnitedKingdom\n\nhttps://media.pubeurope.com/media_attachments/files/114/395/881/365/226/386/original/7fcd1b5b2a0b7877.webp",
"sig": "2c80fe3ccddce621c392a25625d81167c59c1b6448533b245a545c766e1160a66b0bf776a5ff519c823f41537fcd565055005b953fd0a6b586f8af79089c19d9"
}
